Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02728830
Title A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Stephanie Gaillard, M.D.
Indications

fallopian tube cancer

peritoneum cancer

endometrial cancer

ovary epithelial cancer

Therapies

Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.